Literature DB >> 4613734

Sensitivity of Streptococcus pyogenes to sulphamethoxazole, trimethoprim, and cotrimoxazole.

E Yourassowsky, M P Vanderlinden, E Schoutens.   

Abstract

When tested on Wellcotest (sensitivity test agar, Wellcome) supplemented with lysed horse blood, 59 clinical isolates of beta-haemolytic streptococci, belonging to several serological groups, are all sensitive to sulphamethoxazole, to trimethoprim, and to cotrimoxazole. The results obtained on diagnostic sensitivity test agar (Oxoid) containing lysed horse blood are comparable. When Mueller Hinton agar (Difco) is used, some of these strains are called resistant: this is especially true in the case of sulphamethoxazole.Furthermore, on Mueller Hinton agar, even supplemented with lysed blood, discrepancies between diameters of inhibition zone and MIC values exist for the three drugs tested, strains with a low MIC being considered resistant by the disc method. Such disagreements are not observed with non-streptococcal control strains.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4613734      PMCID: PMC475522          DOI: 10.1136/jcp.27.11.897

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  TREATMENT OF B-HEMOLYTIC STREPTOCCAL INFECTION. A STUDY OF THE PEDIATRIC USE OF SULFAMETHOXAZOLE.

Authors:  J ALBAN
Journal:  Am J Dis Child       Date:  1965-04

2.  Tetracycline resistance of group A beta hemolytic streptococci.

Authors:  H A KUHARIC; C E ROBERTS; W M KIR BY
Journal:  JAMA       Date:  1960-12-03       Impact factor: 56.272

3.  Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin.

Authors:  E Sanders; M T Foster; D Scott
Journal:  N Engl J Med       Date:  1968-03-07       Impact factor: 91.245

4.  Regression line analysis of the synergistic effect for the combination of trimethoprim-sulphamethoxazole.

Authors:  K Dornbusch
Journal:  Chemotherapy       Date:  1971       Impact factor: 2.544

5.  Combined antibacterial action in vitro of trimethoprim and sulphonamides. The in vitro nature of synergy.

Authors:  S R Bushby
Journal:  Postgrad Med J       Date:  1969-11       Impact factor: 2.401

6.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

7.  Trimethoprim: laboratory and clinical studies.

Authors:  J H Darrell; L P Garrod; P M Waterworth
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

8.  The prophylactic use of sulfamethoxypyridazine (kynex) during a streptococcal epidemic.

Authors:  I SCHULTZ; P F FRANK
Journal:  Am J Med Sci       Date:  1958-12       Impact factor: 2.378

  8 in total
  4 in total

1.  Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole?

Authors:  Asha C Bowen; Rachael A Lilliebridge; Steven Y C Tong; Robert W Baird; Peter Ward; Malcolm I McDonald; Bart J Currie; Jonathan R Carapetis
Journal:  J Clin Microbiol       Date:  2012-10-10       Impact factor: 5.948

2.  Susceptibility of anaerobic bacteria to sulfamethoxazole/trimethoprim and routine susceptibility testing.

Authors:  J Wüst; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

Review 3.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

Review 4.  Sulfamethoxazole-Trimethoprim (Cotrimoxazole) for Skin and Soft Tissue Infections Including Impetigo, Cellulitis, and Abscess.

Authors:  Asha C Bowen; Jonathan R Carapetis; Bart J Currie; Vance Fowler; Henry F Chambers; Steven Y C Tong
Journal:  Open Forum Infect Dis       Date:  2017-11-02       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.